Novel Combination Of Cannabis-Like Compound With Classical Psychedelics Searches IP Coverage In US

February 15, 2023 · Benzinga

Israeli-based next-gen psychedelics biotech Clearmind Medicine 

CMND+0.83%+ Free Alerts together with partner clinical-stage pharma company SciSparc

SPRC-0.44%+ Free Alerts has filed three provisional patent applications with the United States Patent and Trademark Office (USPTO).

The patents cover psychedelic-based therapeutics, including monotherapy and novel combinations of SciSparc’s CannAmide and classical psychedelics.

More specifically, the patent applications refer to proprietary combinations of LSD, psilocybin, and DMT with SciSparc’s Palmitoylethanolamide (PEA), a cannabimimetic compound and the active ingredient of its proprietary CannAmide drug.

The fruitful collaboration between both companies has previously led Clearmind to file three other U.S. patent applications, then for the combination of SciSparc’s PEA with Clearmind’s MEAI (5-methoxy-2-aminoindane) for treating Alcohol Use Disorder (AUD,) cocaine addiction, and obesity and its related metabolic disorders.

The new patent applications aim to make use of psychedelic substances that have shown positive clinical results together with CannAmide to potentially offer “a treatment that is more effective, safer, and at lower costs,” according to Clearmind CEO Adi Zuloff-Shani.

The strategy “aligns with the company’s vision to bring patients the newest, most effective treatments while maintaining a high safety profile and a strong IP position to enhance commercial viability.”

SpiSparc CEO Oz Adler says that the new patent applications continue to support the company’s findings of the major role CannAmide plays in SciSparc’s various proprietary combination treatments. 

“All our clinical and pre-clinical studies performed to date, in numerous diseases and conditions, indicated CannAmide’s ability to reduce doses while maintaining therapeutic efficacy and increasing safety,” Adler detailed. “We have great confidence in our collaboration with Clearmind and believe that together we can maximize the therapeutic effect of our products, potentially offering additional solutions for mental health problems with unmet needs that have limited effective solutions, if at all.” (Full Story)

In categories:Medical Psychedelics
Next Post

Nasdaq Gets a Healthy Dose of Psychedelics With Lucy Scientific

Lucy Scientific Discovery Inc. (Nasdaq: LSDI), which focuses on psychotropic drugs and had its initial public offering last week, rang the closing bell at the Nasdaq stock exchange today in New York. The company is focused on becoming the premier research, development, and…
Previous Post

From Perpetual Otherness To Artistic Triumph: Exploring Identity Through Psychedelic Art With SpookyGirl’s Andi Astra

Stepping into the world of illustrator Andi Astra, founder and creative director of SpookyGirl, a colorful home decor, art and apparel brand that boasts more than 150.000 social media followers, is like taking a journey to a different universe. From their…
Random Post

The Marijuana Industry's Secret Playbook to Get Weed Legalized in All 50 States - Put Abortion Rights Vote on the Same Ballot?

First it was Ohio with a pro-choice, pro-weed ballot and vote this year that put recreational cannabis in the hands of voters over 21 years-old in Ohio. Cannabis advocates, sensing a pro-legalization win by drawing out female, liberal, progressive voters, are trying…
Random Post

Congress Postpones First-Ever Hearing On Psychedelics And Veterans Mental Health Care

A congressional subcommittee’s hearing on the use of psychedelic-assisted treatments for mental health disorders that was originally scheduled for Thursday has been postponed, the panel announced after another failed vote to elect a House speaker on Wednesday. It’s not yet…
Random Post

Canada’s cannabis ‘strategy table’ quietly met over summer

A group that was supposed to have been created by the Canadian government almost two years ago to shine a light on major issues confronting the nation’s struggling cannabis industry is, for the first time, showing signs of life. A…
Random Post

10 Best-Rated Dispensaries in Las Vegas

With continued market expansion, gaining traction as a dispensary isn’t getting any easier. For operators trying to succeed in major cities with legal adult-use markets for interested tourists, standing out requires an even more pointed effort. Cannabis has been legal for adults…